Stock market announcement archive

April 9, 2024
Bergen, Norway, April 9th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Annual Report 2023. – The technology development and company progress were fantastic in 2023. We expect nothing less in 2024, in our mission to make life easier for patients […]
Read more
February 27, 2024
Bergen, Norway, February 27th, 2024: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q4 financial report and operational update. Lifecare holds steady a course towards the upcoming automated pilot production. The first three quarters of 2023, Lifecare reported on huge achievements both […]
Read more
November 14, 2023
Bergen, Norway, November 14th, 2023: Today, Lifecare AS (LIFE) (the “Company”), a clinical stage medical sensor company developing the next generation Continuous Glucose Monitor (CGM), publishes Q3 financial report and operational update. Lifecare completed Q3 with many important technology and operational achievements. The Company is shifting focus from conducting research and development to focusing on […]
Read more
March 28, 2023
For Lifecare 2022 was characterized by confirmation of the technology, ClinicalDevelopment Study, and building an organization that makes us even more robustand competent to face upcoming challenges. - Important milestone achievementsnaturally provide a good basis for the ongoing work related to the glucosesensor, CEO Joacim Holter states.- Our organization proved its capacity in full strength […]
Read more
February 28, 2023
Bergen, Norway 28 February 2023Today Lifecare publish Q4 2022 interim report. The consolidated group financials show a revenue in Q4 of 5.31 MNOK, compared to1,6 MNOK in Q4 2021. The unaudited interim figures for 2022 show a revenue of20,7 MNOK compared to 1,6 MNOK in 2021. The report is attached to this releaseand are also […]
Read more
December 6, 2022
Bergen, Norway 6.12.2022Today Lifecare announces all-time high revenue in their financial reporting forQ3 2022. - We are pleased to see a positive outcome of the investments we havemade. Furthermore, this provides a base for LifecareŽs continued research andproduct development, says CEO Joacim Holter.The consolidated group financials show a revenue of 15,4 MNOK for the first […]
Read more
December 6, 2022
Bergen, Norway 6 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcasttoday, Tuesday 6 December. The webcast will be for all shareholders andinterested parties at 13:00 - 14:00 CET. Lifecare CEO Joacim Holter will participate in the webcast.There will be a Q&A session following the presentation. The webcast will […]
Read more
December 1, 2022
Bergen, Norway 1 December 2022 Lifecare AS will present Q3 2022 financial and operational status in a webcastTuesday 6 December. For more information of the webcast and other news, read Lifecare's latestnewsletter: https://lifecare.no/news/information-from-lifecare-november-2022/This is Lifecare: Lifecare is a Bergen-based technology company developing a miniaturizedimplantable long-term sensor for correct and continuous monitoring of bloodsugar in people […]
Read more
August 25, 2022
Bergen, 25 August 2022. Today, Lifecare present strong financial results following the first half-yearwith operational activities in two German subsidiaries as part of the LifecareGroup. The external revenue in 1H 2022 reached a total of 8,7MNOK, representingan increase of +8,7MNOK from 1H 2021 (from 0,0 MNOK) and +7,1MNOK from EY 2021(from 1,6MNOK). A steep increase […]
Read more